Andrographolide can block the IL-4R-STAT6 pathway in the colon tissue of mice with ulcerative colitis, effectively inhibit the oxazolinone-induced inflammatory response; reduce inflammatory cell infiltration; and decrease the levels of IL-4, IL-13, and TNF-α (Zhang et al., 2019a). Here, IL4 is linked to ulcerative colitis.